Combination of pioglitazone, a PPARγ agonist, and synthetic surfactant B-YL prevents hyperoxia-induced lung injury in adult mice lung explants

By sjmartinez • March 13, 2023

Kurihara C, Sakurai R, Chuang TD, Waring AJ, Walther FJ, Rehan VK. Combination of pioglitazone, a PPARγ agonist, and synthetic surfactant B-YL prevents hyperoxia-induced lung injury in adult mice lung explants. Pulm Pharmacol Ther. 2023 Mar 10:102209. doi: 10.1016/j.pupt.2023.102209. Epub ahead of print. PMID: 36907545.

Tags: General Internal Medicine, Harbor UCLA, Hyperoxia, Lung injury, Pioglitazone, PPARγ, Publications, Surfactant

Evaluation of the Reliability and Validity of the Retirement Knowledge Scale (RKS)

Blanco LR, Hays RD. Evaluation of the Reliability and Validity of the Retirement Knowledge Scale (RKS). J Retire. 2024 Fall;12(2):76-94. doi: 10.3905/jor.2024.1.164. Epub 2024 Oct[...]

Association of BRAF V600E allele frequency with clinicopathologic outcomes in papillary thyroid cancer

Schumm MA, Nikiforov YE, Nikiforova MN, Wald AI, Tseng CH, Smooke-Praw S, Wu JX, Yeh MW, Livhits MJ. Association of BRAF V600E allele frequency with[...]

Referrals and Black-White Coronary Heart Disease Treatment Disparities: A Qualitative Study of Primary Care Physician Perspectives

Qureshi N, Berry S, Damberg CL, Gibson B, Popescu I. Referrals and Black-White Coronary Heart Disease Treatment Disparities: A Qualitative Study of Primary Care Physician[...]